Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II Pilot Study of Tricycloside Phosphate for Unresectable, Metastatic, or Recurrent Pancreatic Islet Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				NCCTG-834451 MAYO-834451, NCCTG-83-44-51


2.		Phase II Chemotherapy with TCN-P for Advanced, Measurable Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				MAYO-844601 NCI-T84-0233D, T84-0233


3.		Phase II Chemotherapy with TCN-P in Patients with Refractory Ovarian Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-84-C-175A NCI-MB-191, NCI-T84-0483N, T84-0483


4.		Phase II Chemotherapy with Tricyclic Nucleotide Phosphate Administered as a 5-Day Continuous Infusion in Adult Patients with Refractory Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 and over				NCI				MDA-DM-8414 NCI-T84-0407D, T84-0407


5.		Phase II Chemotherapy with Tricyclic Nucleotide Phosphate Administered as a 5-Day Continuous Infusion in Patients with Advanced Epithelial Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 and over				NCI				MDA-DM-8483 NCI-T85-0055C, T85-0055

Last Modified: 2/1/1989


6.		Phase II Master Protocol Chemotherapy for Advanced Squamous Cell Carcinoma of the Cervix --- Tricyclic Nucleoside Phosphate (Summary Last Modified 02/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				any age				NCI				GOG-76Q

Last Modified: 11/1/1989


7.		Phase II Trial of Triciribine Phosphate in Patients with Advanced non-Small Cell Lung Cancer (Summary Last Modified 11/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18				NCI				JH-ONC-113 NCI-T89-0099O, T89-0099


8.		Phase I Study of Tricyclic Nucleoside 5'-Phosphate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				no age specified								NCI-W81-0772 WSU-A-41881, W81-0772


9.		Phase I Evaluation of Tricyclic Nucleoside 5'-Phosphate (NSC-280594)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				over 15								NCI-W81-0474 MDA-DT-8139


10.		Phase I Study of TCN-P (NSC-280594)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				no age specified								NCI-W81-0771 RWGH-8140253

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute